Vitalyze Me úde e Tecnologia : Notice to Shareholders - Reverse Stock Split

Advanced Digital Health Preventive Medicine S.A. ('Company'), a publicly-held company headquartered in the city of Barueri, State of São Paulo, at Al. Tocantins, 125, CEP 06455-931, in compliance with the provisions of art. 157, paragraph 4 of Law 6,404, dated December 15, 1976, as amended ('Corporate Law'), and Instruction No. 358 of January 3, 2002, as amended ('ICVM 358 / 02 ') hereby informs its shareholders and the market in general, as follows:

The Extraordinary General Meeting of the Company, held on January 20, 2017, approved a reverse split of the total of thirty million, two hundred and fifty thousand, three hundred and ninety-five (30,250,395) registered common shares with no par value, of the Company, in the proportion of 4 (four) shares to form 1 (one) share, without modification of the capital stock, resulting in 7,562,598 (seven million, five hundred, sixty two thousand, five hundred and ninety eight) common, nominative, book-entry shares, with no par value, issued by the Company, pursuant to the proposal of the Board of Directors.

The main characteristics and impacts of the reverse split are duly described in the following items:

1. Reverse split ratio: 4 (four) shares to form 1 (one) share.

2. Impact on capital stock: after the reverse split, the Company's capital stock remains in the amount of thirty-three million, eight hundred and sixty thousand, two hundred and twenty-eight reais and eighty-four centavos (R$ 33,860,228.84), but is now divided into 7,562,598 (seven million, five hundred and sixty-two thousand, five hundred and ninety-eight) common, registered, book-entry shares with no par value.

3. Treatment of fractions: Possible fractions of shares resulting from the reverse split will be completed by fractions of shares to be donated, directly or indirectly, by the Company's controlling shareholder, Metropolis Capital Martkets GmbH, so that each shareholder of the Company receives the fraction necessary to guarantee ownership of the next whole number of shares after the application of the approved reverse split factor.

4. Change in shareholder participation: The reverse split will be operationalized and effected so as not to change the proportional participation of the shareholders in the Company's capital stock and will not affect the equity and political rights of the shares issued to the Company.

5. Trading of shares: The Company's grouped shares will be traded on the first business day after the Extraordinary Shareholders' Meeting, on January 23, 2017.

Settlement of operations with positions not yet grouped shall be valid until January 20, 2017, inclusive, considering that the Company's shares will be traded grouped as from January 23, 2017, date of the first BM&FBovespa after the Extraordinary General Meeting that will deliberate on the reverse split of the Company's shares.

The Company reiterates its commitment to keep shareholders informed of the progress of this and any other matter of market interest.

To access the document, click here.

São Paulo, January 20, 2017
Natasha Namie Nakagawa
Director of Investor Relations
[e-mail]
Tel. [phone] / 6749